Real-time monitoring safety during brachytherapy treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new monitoring device during brachytherapy—a targeted radiation treatment for prostate cancer or cervical cancer. The device tracks radiation dose in real time to help doctors ensure the treatment is safe and accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive brachytherapy for prostate cancer OR cervical cancer
- You do not have a Clostridium difficile infection (a serious bowel infection)
- You do not have any other active, high-risk infection at the time of treatment
- You are able to undergo the standard brachytherapy procedure with the added monitoring device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to measure the exact radiation dose you receive during internal radiotherapy (brachytherapy). It aims to make treatment safer and more effective for prostate or gynecologic cancers.
This trial is testing a new way to treat prostate cancer by placing a tiny radioactive seed directly into the main tumor. It's for men with early-stage, slow-growing cancer who have just one visible tumor on MRI.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.